It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

Bill Taranto
President, Merck Global Health Innovation Fund
Jin Lee, Ph.D
Director of Digital Health, Astellas Pharma

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

19th July @ 10:45AM EDT

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Participants

Participants

Bill Taranto

President, Merck Global Health Innovation Fund

Jin Lee, Ph.D

Director of Digital Health, Astellas Pharma

Sheila Woodhouse

Senior Director, Digital Health Lead, Global Drug Development, Bristol Myers Squibb

Chris Cera

CEO, Arcweb Technologies

Uma Makhija Verma

Director, Business Development, Digital Health Lead, Biogen

Zina Manji

Sr Director of Regulatory Affairs at GSK

Tracy Lahey

Strategy & Business Development, Digital Health & Innovation at Amgen

Daniel Hach

COO of BI X - the digital lab of Boehringer Ingelheim

Hassan Naqvi

Lead, External Alliances and Digital Partnerships at AstraZeneca

Jeremy Sohn

Managing Partner, Private Healthcare Ventures at Magnetar Capital

Ary Deleray

Personalized & Digital Health Strategy at Roche

Jeff Wandzura

CEO, KEEP Labs

Alba Zurriaga Carda, PhD

Director of Digital Investments, Sanofi Ventures

Number of Participants


Up to 12
Date  
July 19, 2022
Community

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

Participate in the Meeting

HealthXL Meetings

HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.

Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.

Digital Health Meetings are fully interactive and promote conversation - be ready to talk!

Participant-Led

HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.

Developed for a Busy Schedule

No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.

A Community to connect and network

Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.

continueD learning

Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.

Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Commentary
August 10, 2022
Sprint: Virtual Care in Oncology: HCPs and Patient Adoption
Sprint: Virtual Care in Oncology: HCPs and Patient Adoption
Read More
Commentary
August 5, 2022
ICYMI 3 Big News Stories from July
ICYMI 3 Big News Stories from July
Read More
Commentary
August 5, 2022
Five Expert Insights from the HealthXL Community
Five Expert Insights from the HealthXL Community
Read More

Frequently Asked Questions

What is a HealthXL Digital Health Meeting?

HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.

read more
view Less

How can I become a member of the Digital Health Community?

We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.

read more
view Less

When can I access the Meeting recording?

Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.

read more
view Less

I am participating in this meeting, but can't attend anymore. Can I cancel it?

It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.

read more
view Less

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT
Digital Health in Oncology

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

19th July @ 10:45AM EDT
Digital Health in Oncology
Bill Taranto
President, Merck Global Health Innovation Fund
LinkedIn Profile
Jin Lee, Ph.D
Director of Digital Health, Astellas Pharma
LinkedIn Profile
Sheila Woodhouse
Senior Director, Digital Health Lead, Global Drug Development, Bristol Myers Squibb
LinkedIn Profile
Chris Cera
CEO, Arcweb Technologies
LinkedIn Profile
Uma Makhija Verma
Director, Business Development, Digital Health Lead, Biogen
LinkedIn Profile
Zina Manji
Sr Director of Regulatory Affairs at GSK
LinkedIn Profile
Tracy Lahey
Strategy & Business Development, Digital Health & Innovation at Amgen
LinkedIn Profile
Daniel Hach
COO of BI X - the digital lab of Boehringer Ingelheim
LinkedIn Profile
Hassan Naqvi
Lead, External Alliances and Digital Partnerships at AstraZeneca
LinkedIn Profile
Jeremy Sohn
Managing Partner, Private Healthcare Ventures at Magnetar Capital
LinkedIn Profile
Ary Deleray
Personalized & Digital Health Strategy at Roche
LinkedIn Profile
Jeff Wandzura
CEO, KEEP Labs
LinkedIn Profile
Alba Zurriaga Carda, PhD
Director of Digital Investments, Sanofi Ventures
LinkedIn Profile

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

How can we leverage technological advancements to drive an explosive evolution in pathology? 

Digital pathology has shown many advantages such as improved sample analysis, fewer errors, reduced long-term costs, and better diagnostic results in less time, which ultimately leads to better patient outcomes. Many investors and pharma companies have realized the potential of digital pathology technologies in oncology, as well as the use of real-world evidence (RWE) and data (RWD). Join this masterclass led by Bill Taranto, President of the Merck Global Health Innovation Fund, to discuss and learn more about:

  • How technological advancements will drive an explosive evolution in pathology due to slide scanning, cloud computing/data storage, and Artificial Intelligence (AI). 
  • Where to invest? What do investors think about digital pathology? What gaps can it fill within pharma (in discovery, diagnostic, commercial, etc.)?
  • How RWD and RWE are the new Digital “DNA”, a composite of real-world data quality and volume, network scale & diversity, and digital health services, predicts the ability to execute valuable business use cases.
  • What are the things investors look at when investing in RWD solutions?

When:
19th July @ 10:45AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.